168 related articles for article (PubMed ID: 11510981)
1. Caspase inhibition: a potential therapeutic strategy in neurological diseases.
Rideout HJ; Stefanis L
Histol Histopathol; 2001 Jul; 16(3):895-908. PubMed ID: 11510981
[TBL] [Abstract][Full Text] [Related]
2. Implication of Caspase-3 as a Common Therapeutic Target for Multineurodegenerative Disorders and Its Inhibition Using Nonpeptidyl Natural Compounds.
Khan S; Ahmad K; Alshammari EM; Adnan M; Baig MH; Lohani M; Somvanshi P; Haque S
Biomed Res Int; 2015; 2015():379817. PubMed ID: 26064904
[TBL] [Abstract][Full Text] [Related]
3. AMPK in Neurodegenerative Diseases.
Domise M; Vingtdeux V
Exp Suppl; 2016; 107():153-177. PubMed ID: 27812980
[TBL] [Abstract][Full Text] [Related]
4. Activation and regulation of caspase-6 and its role in neurodegenerative diseases.
Wang XJ; Cao Q; Zhang Y; Su XD
Annu Rev Pharmacol Toxicol; 2015; 55():553-72. PubMed ID: 25340928
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
Chabrier PE; Demerlé-Pallardy C; Auguet M
Cell Mol Life Sci; 1999 Jul; 55(8-9):1029-35. PubMed ID: 10442086
[TBL] [Abstract][Full Text] [Related]
6. Caspase-6 and neurodegeneration.
Graham RK; Ehrnhoefer DE; Hayden MR
Trends Neurosci; 2011 Dec; 34(12):646-56. PubMed ID: 22018804
[TBL] [Abstract][Full Text] [Related]
7. Caspase-3 in the central nervous system: beyond apoptosis.
D'Amelio M; Sheng M; Cecconi F
Trends Neurosci; 2012 Nov; 35(11):700-9. PubMed ID: 22796265
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription.
Tatton WG; Chalmers-Redman RM; Ju WY; Wadia J; Tatton NA
J Neural Transm Suppl; 1997; 49():245-68. PubMed ID: 9266433
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.
Endres M; Namura S; Shimizu-Sasamata M; Waeber C; Zhang L; Gómez-Isla T; Hyman BT; Moskowitz MA
J Cereb Blood Flow Metab; 1998 Mar; 18(3):238-47. PubMed ID: 9498840
[TBL] [Abstract][Full Text] [Related]
10. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
Waldmeier PC
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
[TBL] [Abstract][Full Text] [Related]
11. Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis.
Allen JW; Eldadah BA; Huang X; Knoblach SM; Faden AI
J Neurosci Res; 2001 Jul; 65(1):45-53. PubMed ID: 11433428
[TBL] [Abstract][Full Text] [Related]
12. Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders.
Lesort M; Lee M; Tucholski J; Johnson GV
J Biol Chem; 2003 Feb; 278(6):3825-30. PubMed ID: 12458211
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke.
Akpan N; Serrano-Saiz E; Zacharia BE; Otten ML; Ducruet AF; Snipas SJ; Liu W; Velloza J; Cohen G; Sosunov SA; Frey WH; Salvesen GS; Connolly ES; Troy CM
J Neurosci; 2011 Jun; 31(24):8894-904. PubMed ID: 21677173
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture.
Gharibani PM; Modi J; Pan C; Menzie J; Ma Z; Chen PC; Tao R; Prentice H; Wu JY
Adv Exp Med Biol; 2013; 776():241-58. PubMed ID: 23392887
[TBL] [Abstract][Full Text] [Related]
15. Caspases as drug targets in ischemic organ injury.
Faubel S; Edelstein CL
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):269-87. PubMed ID: 16178788
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome C and caspase-9 expression in Huntington's disease.
Kiechle T; Dedeoglu A; Kubilus J; Kowall NW; Beal MF; Friedlander RM; Hersch SM; Ferrante RJ
Neuromolecular Med; 2002; 1(3):183-95. PubMed ID: 12095160
[TBL] [Abstract][Full Text] [Related]
17. Caspase pathways, neuronal apoptosis, and CNS injury.
Eldadah BA; Faden AI
J Neurotrauma; 2000 Oct; 17(10):811-29. PubMed ID: 11063050
[TBL] [Abstract][Full Text] [Related]
18. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release.
Zhang Y; Bhavnani BR
BMC Neurosci; 2005 Feb; 6():13. PubMed ID: 15730564
[TBL] [Abstract][Full Text] [Related]
19. Specificity of biophysical and biochemical alterations in erythrocyte membranes in neurological disorders--Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and duchenne muscular dystrophy.
Butterfield DA; Markesbery WR
J Neurol Sci; 1980 Aug; 47(2):261-71. PubMed ID: 6251175
[TBL] [Abstract][Full Text] [Related]
20. The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain.
Fossati S; Giannoni P; Solesio ME; Cocklin SL; Cabrera E; Ghiso J; Rostagno A
Neurobiol Dis; 2016 Feb; 86():29-40. PubMed ID: 26581638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
